Publication: PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.
Issued Date
2017
Resource Type
Language
eng
Rights
Mahidol University
Rights Holder(s)
BioMed Central
Bibliographic Citation
Lipids in Health and Disease. Vol. 16, No.1 (2017), 80
Suggested Citation
Yaowapa Maneerat, Kriengchai Prasongsukarn, Surachet Benjathummarak, Wilanee Dechkhajorn PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.. Lipids in Health and Disease. Vol. 16, No.1 (2017), 80. doi:10.1186/s12944-017-0471-0 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/43780
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.
Abstract
Background: Coronary heart disease (CHD) is an important complication of atherosclerosis. Biomarkers, which
associate with CHD development, are potential to predict CHD risk. To determine whether genes showing altered
expression in hyperlipidaemia (H) and coronary heart disease (CHD) patients compared with controls could be CHD
risk biomarkers.
Methods: Control, H, and CHD groups represented atherosclerosis to CHD development. Gene profiling was
investigated in peripheral blood mononuclear cells using DNA microarrays. Eight selected genes expressed only in H
and CHD groups were validated by real-time quantitative reverse transcription PCR and plasma protein determination.
Results: α-defensin (DEFA1/DEFA3), pro-platelet basic protein (PPBP), and beta and alpha2 hemoglobin mRNA
expression was significantly increased in H and CHD groups compared with controls, but only plasma PPBP and
α-defensin proteins were correspondingly increased.
Conclusion: PPBP and DEFA1/DEFA3 could be potential CHD biomarkers in Thai hyperlipidaemia patients.